SIG
BSX icon

Stanford Investment Group’s Boston Scientific BSX Stock Holding History

Stanford Investment Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$4K – 45
2016
Q4 		$4K Hold
200
– – ﹤0.01% 339
2016
Q3 		$5K Buy
+200
New +$4.77K ﹤0.01% 362

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Stanford Investment Group's BSX Position: Q1 2017 in Review

Stanford Investment Group sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 200 shares — an estimated $4K sold.

Stanford Investment Group first reported a position in BSX in Q3 2016 and held it in 2 quarters. The position peaked at $5K in Q3 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • Stanford Investment Group reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 200 Boston Scientific shares in Q1 2017, an estimated $4K.
  • Stanford Investment Group first reported a position in Boston Scientific in Q3 2016 and held it in 2 quarters.
  • Stanford Investment Group's Boston Scientific position peaked at $5K in Q3 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.